Qian Li

Qian Li

Auto-generated profile, based on publicly available information

Qian Li

Department of Radiation Oncology, The Fifth Medical Center of PLA General Hospital, Beijing, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 November 2022 in BMC Gastroenterology
Verified
Journal Article
Open access
PDF file
DZDan Zhang
Dan Zhang
QLQian Li
Qian Li
DLDong Li
Dong Li
JJJun Jia
Jun Jia
JDJunQiang Ding
JunQiang Ding
XDXuezhang Duan
Xuezhang Duan
Background: The aim of our study was to evaluate the curative effect and safety of stereotactic body radiation therapy (SBRT) in treating hepatocellular carcinoma (HCC) patients with inferior vena cava (IVCTT) and right atrial tumor thrombus (RATT). Methods: This retrospective study included fifteen advanced HCC patients with IVCTT and RATT who were treated with SBRT between 2013 and 2020. The prescribed dose delivered to the tumor was 45–50 Gy/7–10 fx. We report their treatment responses according to survival time and toxicities. Results: For these patients, the median follow-up time was 15 months (2–52 months). Local tumor control rates of the treated area were 80% at the time of death or at the last follow-up. The 6-month, 12-month, 18-month and 24-month OS rates were 80.0%, 60.0%, 33.3% and 26.7%, respectively. None of these patients died from the toxicity outcomes and complications of SBRT. Conclusion: SBRT is an effective option for advanced HCC patients with IVCTT and RATT.